IPA questions FAERS data interpretation in the Ohio State University study
Express Pharma
MARCH 12, 2025
It attributed Indias cost advantage to high-production capacity plants, process improvements, economies of scale, and backward integration in manufacturing. IPA also addressed concerns regarding transparency in drug manufacturing locations.
Let's personalize your content